Tag: DOJ

Government’s Annual Health Care Fraud Results Released: $4.3 Billion Recovered in 2013

The Department of Health and Human Services (DHHS) and The Department of Justice (DOJ) Health Care Fraud and Abuse Control (HCRAC) Program Annual Report for Fiscal Year 2013 (Report) was released this week.  The Report states that the DHHS and DOJ recovered $4.3 billion in health care fraud judgments and settlements in fiscal year 2013.  […]

The U.S. Solicitor General Files Memorandum Opposing Injunction on ACA’s Contraceptive Mandate

On Friday, January 3, 2014, the U.S. Solicitor General filed a memorandum in opposition to the emergency application for an injunction temporarily granted by the U.S. Supreme Court on December 31, 2013. The injunction temporarily enjoined the government from enforcing the contraceptive coverage requirements imposed by the Affordable Care Act (ACA) and its related […]

LITIGATION ROUND-UP

Settlements The U.S. Department of Justice (DOJ) announced on Friday that it reached a nearly $5.5 million settlement with Abbott Laboratories to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company’s carotid, biliary and peripheral vascular products.  The alleged kickbacks […]

Johnson & Johnson Finalizes $2.2 Billion Government Settlement

Earlier this week, the U.S. Department of Justice (DOJ) announced that it reached a settlement with Johnson & Johnson (J&J) and two of its subsidiaries — Janssen Pharmaceuticals and Scios Inc. — to resolve civil and criminal health care fraud allegations. The settlement in principle was first announced by J&J […]

LITIGATION ROUND-UP

Settlements On October 15th, Fougera Pharmaceuticals agreed to pay $22.75 million to resolve civil allegations related to Medicaid drug pricing claims.  The government alleged that between September 1995 and October 2013, Fougera knowingly set, reported and maintained fraudulent and/or inflated pricing information for certain drugs that resulted in overpayments by […]

LITIGATION ROUND-UP

Settlements Sanofi-Aventis reached a settlement in August 2013 with the Maryland Attorney General and other states for alleged violations of federal and state anti-kickback statutes related to its osteoarthritis drug Hyalgan.  The government alleged that Sanofi provided free Hyalgan units with knowledge that doctors could receive Medicaid reimbursement and/or were expected to buy additional quantities […]

Two Oregon HCPs Settle with DOJ for Failing to Disclose Relationships with Industry

Earlier this month it was reported that two Oregon physicians entered into settlement agreements with the Oregon Department of Justice (DOJ) for failing to inform their patients of relationships with a medical device manufacturer. The civil action was brought by the Oregon DOJ under the Oregon Unlawful Trade Practices Act.  The physicians […]